evel of IgG Antibodies against Covid19 in people of Ahmedabad as on February 2021
Not Applicable
- Registration Number
- CTRI/2021/02/031165
- Lead Sponsor
- Ahmedabad Municipal Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Those who give written informed consent
Exclusion Criteria
any bleeding disorder, contraindication to venipuncture & hospitalized patients
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Seroprevalence of IgG Antibodies against SARS-CoV-2 in general population of AhmedabadTimepoint: 1 (since this is a cross sectional study (A serosurveillance using Covid-Kavach - IgG antibody for SARS-CoV2) there is only 1 time-point)
- Secondary Outcome Measures
Name Time Method Factors Affecting IgG antibody based Immunity against SARS-CoV-2 infectionTimepoint: 1 (since this is a cross sectional study (A serosurveillance using Covid-Kavach - IgG antibody for SARS-CoV2) there is only 1 time-point)